US Map / Washington D.C.
State DC

Clinical Trials in Washington D.C.

Washington D.C. is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Washington D.C. and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 114 actively recruiting studies with Washington D.C. sites out of 114 registered in total. The busiest research areas in Washington D.C. are Solid Tumor, Colorectal Cancer, Neuroblastoma. Leading sponsors running trials in the state include Children's National Research Institute, National Cancer Institute (NCI), Merck Sharp & Dohme LLC. By stage, Washington D.C. trials break down as Phase 1 (23), Phase 2 (30), Phase 3 (25), Phase 4 (2).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
114
Recruiting Now
114
← Back to US Map
Top Conditions in Washington D.C.
Solid Tumor (4)Colorectal Cancer (3)Neuroblastoma (3)Stroke (3)Crohn Disease (3)Diabetic Peripheral Neuropathic Pain (2)Prostate Cancer (2)Sarcoma (2)Sickle Cell Disease (2)Asthma (2)Large B-cell Lymphoma (2)Becker Muscular Dystrophy (2)

Frequently Asked Questions — Clinical Trials in Washington D.C.

How many clinical trials are currently recruiting in Washington D.C.?
ClinicalMetric currently tracks 114 actively recruiting clinical trials with at least one location in Washington D.C.. The total number of registered studies—including active but not currently enrolling trials—is 114. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Washington D.C.?
Washington D.C. hosts clinical trials across a broad range of medical conditions, including Solid Tumor, Colorectal Cancer, Neuroblastoma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Washington D.C. serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Washington D.C.?
To join a clinical trial in Washington D.C., browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Washington D.C. maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Washington D.C.

NCT02699957 N/A
Recruiting
Left Atrial Appendage Occlusion Registry (LAAO Registry)
Condition
Atrial Fibrillation
Enrollment
3,000 pts
Location
United States
Sponsor
American College of Cardiology
View Trial →
NCT07020819 Phase 3
Recruiting
An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as AN...
Condition
Guillain-Barre Syndrome
Enrollment
30 pts
Location
United States, Denmark, France
Sponsor
Annexon, Inc.
View Trial →
NCT07759128 Phase 3
Recruiting
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With G...
Condition
Generalized Anxiety Disorder
Enrollment
576 pts
Location
United States
Sponsor
Otsuka Pharmaceutical Developm
View Trial →
NCT06256588 Phase 3
Recruiting
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants Wit...
Condition
Neoplasms, Head and Neck
Enrollment
864 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
View Trial →
NCT06618027 N/A
Recruiting
Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concer...
Condition
Type 1 Diabetes (T1D)
Enrollment
200 pts
Location
United States
Sponsor
Children's National Research I
View Trial →
NCT07281079 Phase 3
Recruiting
A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
Condition
Phelan-McDermid Syndrome
Enrollment
160 pts
Location
United States, Canada
Sponsor
Neuren Pharmaceuticals Limited
View Trial →
NCT07549503 Phase 2
Recruiting
Early Signals of the Transition From Immune Quiescence to Activation in the Live...
Condition
Liver Transplant
Enrollment
100 pts
Location
United States
Sponsor
National Institute of Allergy
View Trial →
NCT05389293 Phase 2
Recruiting
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Ly...
Condition
Follicular Lymphoma
Enrollment
152 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
View Trial →
NCT00736749 N/A
Recruiting
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Gro...
Condition
Hematopoietic Cell Transplantation Recipient
Enrollment
25,000 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
View Trial →
NCT04855773 N/A
Recruiting
Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP...
Condition
HIV Infections
Enrollment
300 pts
Location
United States
Sponsor
Public Health Foundation Enter
View Trial →
NCT07293351 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or...
Condition
Advanced Renal Cell Carcinoma (RCC)
Enrollment
474 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
View Trial →
NCT03072927 N/A
Recruiting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Condition
Lumbar Spinal Stenosis
Enrollment
8,000 pts
Location
United States
Sponsor
Stryker Instruments
View Trial →
NCT06635902 Phase 2
Recruiting
Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease
Condition
Sickle Cell Disease
Enrollment
99 pts
Location
United States
Sponsor
Suvankar Majumdar
View Trial →
NCT06703073 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
600 pts
Location
United States
Sponsor
PPD Development, LP
View Trial →
NCT05230173 N/A
Recruiting
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remi...
Condition
Ulcerative Colitis
Enrollment
216 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT05977686 N/A
Recruiting
Hemoglobin Testing in Pregnant Patients
Condition
Post Partum Hemorrhage
Enrollment
250 pts
Location
United States
Sponsor
Inova Health Care Services
View Trial →
NCT07635329 N/A
Recruiting
Home-based Vision Rehabilitation Guided by Brain Imaging
Condition
Visual Field Defect
Enrollment
100 pts
Location
United States
Sponsor
Georgetown University
View Trial →
NCT05768919 Phase 1, Phase 2
Recruiting
Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newl...
Condition
Glioblastoma
Enrollment
30 pts
Location
United States
Sponsor
SignPath Pharma, Inc.
View Trial →
NCT07746167 N/A
Recruiting
Pupillary Dilation Reflex in Healthy Volunteers
Condition
Healthy Participants
Enrollment
60 pts
Location
United States
Sponsor
Children's National Research I
View Trial →
NCT06863272 Phase 1, Phase 2
Recruiting
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Mon...
Condition
Castration-Resistant Prostatic Cancer
Enrollment
360 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT05272241 N/A
Recruiting
Registry of Asthma Characterization and Recruitment 3 (RACR3)
Condition
Asthma
Enrollment
1,500 pts
Location
United States
Sponsor
National Institute of Allergy
View Trial →
NCT04661137 Phase 2
Recruiting
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomi...
Condition
Multiple Myeloma
Enrollment
96 pts
Location
United States
Sponsor
Hackensack Meridian Health
View Trial →
NCT06554795 Phase 1, Phase 2
Recruiting
First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors
Condition
Solid Tumor, Adult
Enrollment
360 pts
Location
United States, Australia, China
Sponsor
DualityBio Inc.
View Trial →
NCT07538609 N/A
Recruiting
The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study
Condition
Venous Thromboses
Enrollment
150 pts
Location
United States
Sponsor
W.L.Gore & Associates
View Trial →
Page 4 of 5 — 114 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology